# OnCo record bcma (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/bcma/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "bcma" ;
  schema:name "BCMA"@en ;
  schema:description "BCMA is a survival receptor on plasma cells, and the target that made CAR-T and bispecifics work in multiple myeloma."@en ;
  schema:url <https://onco.cc/targets/bcma/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/B-cell_maturation_antigen>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11913>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000048462>, <https://www.uniprot.org/uniprotkb/Q02223/entry>, <https://www.ncbi.nlm.nih.gov/gene/608> ;
  owl:sameAs <http://www.wikidata.org/entity/Q17847640> ;
  schema:citation <https://en.wikipedia.org/wiki/B-cell_maturation_antigen> ;
  onco:tag "car-t-target", "t-cell-engager-target" ;
  schema:alternateName "TNFRSF17" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "1992"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/bcma-expression/> ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/gc012f/>, <https://onco.cc/drugs/azd4045/>, <https://onco.cc/drugs/nxc-201-car-t/> ;
  onco:companies <https://onco.cc/companies/arcellx/>, <https://onco.cc/companies/cullinan-therapeutics/>, <https://onco.cc/companies/kelonia-therapeutics/>, <https://onco.cc/companies/poseida-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct05594797/> .
